Microvascular disease: what does the UKPDS tell us about diabetic nephropathy?

Diabetic Medicine : a Journal of the British Diabetic Association
R Bilous

Abstract

The UK Prospective Diabetes Study is the largest study in Type 2 diabetes with pre-specified renal outcomes. The study showed that the natural history of nephropathy in newly diagnosed Type 2 diabetic patients was similar to that described previously in those with Type 1 diabetes. Around 2% per annum progress from normo- to micro-albuminuria [urinary albumin concentration (UAC) > 50 mg/l] and a further 2% from microalbuminuria to clinical grade proteinuria (UAC > 300 mg/l). Mortality rates for those with nephropathy are high, increasing from 1.4% per annum (normoalbuminuria) to 4.6% per annum (clinical grade proteinuria), and to 19.2% per annum for those with renal impairment. More intensive blood glucose control resulted in both a 33% reduction in relative risk of development of microalbuminuria or clinical grade proteinuria at 12 years, and a significant reduction in the proportion doubling their plasma creatinine (0.91 vs. 3.52%, P = 0.0028). Tighter blood pressure control also reduced microalbuminuria and clinical grade proteinuria; but at 6 years there was no effect on plasma creatinine levels. These data underline the importance of glycaemic and blood pressure control in Type 2 diabetes in order to prevent diabetic nephro...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Dec 1, 1996·Diabetologia·P FiorettoR Nosadini
Jan 3, 2001·Kidney International·L F FriedB L Kasiske
Sep 22, 2001·The New England Journal of Medicine·H H ParvingUNKNOWN Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group
Nov 2, 2004·The New England Journal of Medicine·Piero RuggenentiUNKNOWN Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators
May 30, 2006·Diabetes·Ravi RetnakaranUNKNOWN UKPDS Study Group
Dec 6, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·David Ansell

❮ Previous
Next ❯

Citations

Dec 17, 2009·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Robert C Atkins, Paul Zimmet
May 10, 2013·Current Diabetes Reports·Tomohito Gohda, Yasuhiko Tomino
Jan 16, 2013·Primary Health Care Research & Development·Nicola Thomas, Rosamund Bryar
Jan 23, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·R C Atkins, P Zimmet
Apr 10, 2010·Nephrology·Robert C Atkins, Paul Zimmet
Jun 4, 2010·Diabetes, Obesity & Metabolism·S Colagiuri
Mar 21, 2012·Diabetes, Obesity & Metabolism·A J Garber
Aug 28, 2012·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Hajime HaimotoKenji Wakai
Jan 9, 2014·Current Diabetes Reports·Carolina Solis-HerreraJane L Lynch
Sep 27, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Katherine R TuttleMark E Molitch
Jan 26, 2010·Acta Diabetologica·Robert C Atkins, Paul Zimmet
Apr 2, 2013·La Presse médicale·Béatrice BouhanickBernard Chamontin
Jan 8, 2013·The Medical Clinics of North America·Eberhard Ritz
Feb 13, 2010·Kidney International·Robert C Atkins, Paul Zimmet
Oct 14, 2011·Kidney International·William G CouserMarcello Tonelli
Dec 15, 2011·Kidney International·Jeffrey M TurnerThomas H Hostetter
Jan 2, 2010·Diabetes Research and Clinical Practice·Robert C AtkinsUNKNOWN 2010 World Kidney Day Steering Committee (International Society of Nephrology and International Federation of Kidney Foundat
Apr 8, 2015·Diabetes & Metabolic Syndrome·Jamal Ahmad
Feb 2, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Robert C Atkins, Paul Zimmet
Feb 17, 2009·Diabetes/metabolism Research and Reviews
May 5, 2010·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Robert C AtkinsUNKNOWN International Diabetes Federation
Apr 9, 2010·Journal of the American Society of Hypertension : JASH·Robert C AtkinsUNKNOWN World Kidney Day Steering Committee
Jul 8, 2011·Scandinavian Journal of Clinical and Laboratory Investigation·Aleksandra AraszkiewiczBogna Wierusz-Wysocka
Mar 18, 2010·Acta Physiologica Hungarica·Robert C AtkinsUNKNOWN International Diabetes Federation
Dec 4, 2014·Journal of Diabetes and Its Complications·Jeanie B Tryggestad, Steven M Willi
Sep 25, 2014·Diabetes Care·Katherine R TuttleMark E Molitch
Dec 3, 2014·The Medical Clinics of North America·Matthew P Gilbert
Feb 22, 2014·Diabetes Care·George L Bakris, Mark Molitch
Jul 17, 2016·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Xu ZhouXin Sun
Jan 13, 2017·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Shaw Watanabe
Jun 23, 2010·Nature Reviews. Endocrinology·Anne HiukkaMarja-Riitta Taskinen
Jan 21, 2010·Journal of Hypertension·Robert C Atkins, Paul Zimmet
May 20, 2017·Clinical Journal of the American Society of Nephrology : CJASN·Radica Z AlicicKatherine R Tuttle
Oct 27, 2018·Clinical Journal of the American Society of Nephrology : CJASN·Amy K MottlTimothy E Craven
Dec 6, 2019·Pediatric Diabetes·Timothy BarrettUNKNOWN Novo Nordisk Pediatric Type 2 Diabetes Global Expert Panel
Dec 27, 2019·Advances in Anatomic Pathology·Mohammed AkhtarAjayeb Dakhilalla M H Al-Nabet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.